Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Does the IL6 rs1800795 GG genotype increase inflammatory signaling and alter mineral utilization?

The IL6 rs1800795 GG genotype is associated with higher inflammatory signaling and can promote inflammation-driven shifts in iron and zinc handling.

PlausibleJuly 8, 202622 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The IL6 rs1800795 GG genotype is associated with higher inflammatory signaling in some populations, which can amplify inflammation-driven mineral redistribution and utilization.

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This claim says the GG genotype may raise IL-6-related inflammatory tone in some populations. The mechanism frames that inflammatory state as increasing hepcidin and ZIP14 activity, which can sequester iron and zinc away from circulation. The result is reduced mineral availability and altered normal utilization during inflammation.

Verified conclusion

The IL-6 gene promoter polymorphism rs1800795 (-174G>C) modulates systemic inflammatory tone, which directly influences downstream systemic mineral homeostasis.

Genotype and inflammatory signaling

  • Elevated Transcription: The rs1800795 GG genotype is associated with higher promoter activity and increased interleukin-6 (IL-6) transcription compared to C-allele carriers, particularly under physiological stress or inflammatory challenges.
  • Downstream Inflammatory Markers: This heightened transcriptional activity leads to elevated circulating levels of IL-6 and hepatic C-reactive protein (CRP). In clinical cohorts, such as pediatric Crohn's disease patients, individuals carrying the GG genotype present with significantly higher CRP levels at diagnosis compared to C-allele carriers.

Mechanistic mineral redistribution

  • Hepcidin-Mediated Iron Sequestration: Elevated IL-6 binds hepatocyte receptors, activating the JAK2/STAT3 signaling cascade to transcriptionally upregulate the hormone hepcidin. Hepcidin binds to the iron exporter ferroportin on macrophages and enterocytes, inducing its internalization and lysosomal degradation. This blocks cellular iron efflux, trapping recycled iron within intracellular ferritin stores and driving hypoferremia.
  • ZIP14-Driven Hypozincemia: Concurrently, IL-6-induced JAK/STAT3 activation transcriptionally upregulates the zinc importer ZIP14 (SLC39A14) on the basolateral membrane of hepatocytes. Co-activation of intracellular metallothioneins creates an active hepatic "zinc sink," rapidly clearing zinc from the plasma and sequestering it in hepatic tissue.

Bottom line

  • The IL6 rs1800795 GG genotype amplifies systemic inflammatory signaling, driving a JAK/STAT3-mediated cascade that upregulates hepcidin and ZIP14. This process sequesters iron in macrophages and zinc in hepatocytes, causing functional iron deficiency and hypozincemia, which limits systemic mineral availability and impairs normal physiological utilization.

References

  1. Interleukin-6 promoter polymorphism interacts with pain and life ... — pmc.ncbi.nlm.nih.gov ↗
  2. Why Is My DNA Driving Inflammation As I Age? | FitnessGenes® — fitnessgenes.com ↗
  3. [PDF] Polymorphisms rs1800795 of interleukin-6 and rs2228145 of ... — geneticsmr.com ↗
  4. IL-6 polymorphisms: a useful genetic tool for inflammation research? — pubmed.ncbi.nlm.nih.gov ↗
  5. Association of genetic variations of interleukin-6 polymorphism ... — explorationpub.com ↗
  6. Genotype at a promoter polymorphism of the interleukin-6 gene is ... — abdn.elsevierpure.com ↗
  7. rs4129267 - SNPedia — bots.snpedia.com ↗
  8. IL-6 polymorphisms: a useful genetic tool for inflammation research? — pmc.ncbi.nlm.nih.gov ↗
  9. VCV000014718.25 - ClinVar - NCBI - NIH — ncbi.nlm.nih.gov ↗
  10. Interleukin-6 induces hepcidin expression through STAT3. — pmc.ncbi.nlm.nih.gov ↗
  11. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. — pmc.ncbi.nlm.nih.gov ↗
  12. Macrophages and Systemic Iron Homeostasis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  13. Iron as an immunometabolic signal in infection and inflammation — frontiersin.org ↗
  14. The Hepcidin Circuits Act: Balancing Iron and Inflammation - PMC — pmc.ncbi.nlm.nih.gov ↗
  15. Anemia of inflammation: the cytokine-hepcidin link - JCI — jci.org ↗
  16. Interleukin-6 regulates the zinc transporter Zip14 in liver and ... - PNAS — pnas.org ↗
  17. Interleukin-6 regulates the zinc transporter Zip14 in liver ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  18. Influence of ZIP14 (slc39A14) on intestinal zinc processing ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  19. Anemia of inflammation: the cytokine-hepcidin link. — pmc.ncbi.nlm.nih.gov ↗
  20. On Iron Metabolism and Its Regulation — pmc.ncbi.nlm.nih.gov ↗
  21. Emerging Roles of the Iron Chelators in Inflammation — pmc.ncbi.nlm.nih.gov ↗
  22. Zinc Regulates the Acute Phase Response and Serum Amyloid A ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→